Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9453 |
High Similarity |
NPD3027 |
Phase 3 |
0.9091 |
High Similarity |
NPD1613 |
Approved |
0.9091 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8788 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8712 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8356 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8271 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8271 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.82 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8195 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8162 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8133 |
Intermediate Similarity |
NPD1934 |
Approved |
0.811 |
Intermediate Similarity |
NPD228 |
Approved |
0.8102 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8092 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8029 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7986 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7985 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7962 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7961 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7868 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7857 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7846 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7812 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7793 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7769 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7764 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7764 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7763 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7763 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7756 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7734 |
Intermediate Similarity |
NPD2684 |
Approved |
0.773 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7721 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7718 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7717 |
Intermediate Similarity |
NPD968 |
Approved |
0.7677 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7677 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD37 |
Approved |
0.766 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7628 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7628 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7628 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7622 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7609 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7607 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7606 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7594 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7593 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7591 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7584 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7582 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7561 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7552 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7547 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7538 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7538 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7531 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7519 |
Intermediate Similarity |
NPD290 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7468 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7452 |
Intermediate Similarity |
NPD5402 |
Approved |
0.745 |
Intermediate Similarity |
NPD4237 |
Approved |
0.745 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD4162 |
Approved |
0.745 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.745 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7419 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7415 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7402 |
Intermediate Similarity |
NPD291 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7346 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7324 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7323 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7319 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7319 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7303 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD3687 |
Approved |
0.729 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7286 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7278 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7219 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7211 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7211 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7211 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7208 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.719 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.717 |
Intermediate Similarity |
NPD5772 |
Approved |
0.717 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7162 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7161 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7115 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7086 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7075 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7073 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7063 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD3179 |
Approved |
0.7055 |
Intermediate Similarity |
NPD3180 |
Approved |
0.7051 |
Intermediate Similarity |
NPD52 |
Approved |
0.7051 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD3052 |
Approved |
0.7047 |
Intermediate Similarity |
NPD3054 |
Approved |
0.7042 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7039 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7027 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7027 |
Intermediate Similarity |
NPD3059 |
Approved |
0.702 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD6100 |
Approved |
0.702 |
Intermediate Similarity |
NPD6099 |
Approved |
0.702 |
Intermediate Similarity |
NPD2796 |
Approved |
0.702 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7019 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7018 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7018 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7013 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7007
|
Intermediate Similarity |
NPD3144 |
Approved |